EPS Corp Offers CluePoints RBQM Solution


Applied Clinical Trials

EPS Corporation, a Shinjuku-ku, Tokyo-based CRO, has reached an agreement to offer CluePoints’ Risk Based Quality Management (RBQM) solutions to its sponsors. The RBQM tools will complement either new or existing RBM processes through the CluePoints Central Monitoring Platform to allow EPS sponsors drive early risk detection, improve quality and enhance patient safety in clinical trials.

For the full release, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.